HIGHLIGHTS
- who: Farooqahmed S. Kittur and collaborators from the Department of Pharmaceutical Sciences, Biomanufacturing Research Institute and Technology Enterprise have published the Article: Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment, in the Journal: Pharmaceuticals 2023, 16, 610. of /2023/
- what: Taken together, these findings suggest that the impermeability of the BBB to rhuEPOM is unlikely to be the major reason for its failure in stroke clinical trials, and thus other factors must be responsible.
- how: The authors evaluated the in_vitro neuroprotective effect of asialo-rhuEPOP by studying its ability to protect . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.